Skip to main content
Fig. 3 | Journal of Ovarian Research

Fig. 3

From: Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma

Fig. 3

HRD score, homologous recombination mutations, and HRD status predict platinum response. The Pt-sensitive patients showed significantly higher HRD scores than Pt-resistant ones (A). Pt-sensitive patients tend to be enriched in patients with HRD or BRCAm (B) and BRCA mutations or non-BRCA HRR pathway gene mutations (C)

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us